Commentary on 'Mesothelin CAR-T cells expressing tumor-targeted immunocytokine IL-12 yield durable efficacy and fewer side effects'

Subjects

Subjects :

CAR-T cell therapy
Mesothelin
Tumor antigen epitope
IL-12
Combination treatment
Therapeutics. Pharmacology
RM1-950

Details

Language :

English

ISSN :

10961186

Volume :

206

Issue :

107267-

Database :

Directory of Open Access Journals

Journal :

Pharmacological Research

Publication Type :

Academic Journal

Accession number :

edsdoj.075dd376401740959bcdff94e350d275

Document Type :

article

Full Text :

https://doi.org/10.1016/j.phrs.2024.107267